Somaxon Pharmaceuticals, Inc.

(NASDAQ:SOMX)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Assets
Current Assets
Cash & Equivalents 13,631 18,084 12,681 12,554
Restricted Cash 2,216 — — —
Marketable Securities 8,999 15,067 17,050 24,546
Accounts Receivable — — — —
Loans Receivable — — — —
Other Receivable 78 — — 198
Receivables 78 — — 198
Raw Materials — — — —
Work in Progress — — — —
Purchased Components — — — —
Finished Goods — — — —
Other Inventories — — — —
Inventories Adjustments and Allowances — — — —
Inventories — — — —
Prepaid Expenses 345 471 — 103
Current Deferred Income Taxes — — — —
Other Current Assets 967 823 2,543 525
Total Current Assets 26,236 34,445 32,274 37,926
Land and Improvements — — — —
Building and Improvements — — — —
Machinery Furniture and Equipment 859 — 485 485
Construction in Progress — — — —
Other Fixed Assets — 471 — —
Total Fixed Assets 859 471 485 485
Gross Fixed Assets 859 471 485 485
Accumulated Depreciation and Depletion 367 324 324 294
Net Fixed Assets 492 147 161 191
Intangibles — — — —
Cost in Excess — — — —
Non Current Deferred Income Taxes — — — —
Other Non Current Assets 5,963 6,884 600 600
Total Non Current Assets 6,455 7,031 761 791
Total Assets 32,691 41,476 33,035 38,717
Liabilities
Current Liabilities
Accounts Payable 3,690 4,196 1,568 1,174
Notes Payable — — — —
Short Term Debt 3,707 2,275 — —
Accrued Expenses — — — —
Accrued Liabilities 1,595 — 1,415 2,367
Deferred Revenues — — — —
Current Deferred Income Tax Liabilities — — — —
Other Current Liabilities — 1,200 — —
Total Current Liabilities 8,992 7,671 2,983 3,541
Non Current Liabilities
Long Term Debt 10,543 11,834 — —
Capital Lease Obligations — — — —
Deferred Income Tax Liabilities — — — —
Other Non Current Liabilities 71 22 — —
Minority Interest Liabilities — — — —
Preferred Securities of Subsidiary Trust Liabilities — — — —
Preferred Equity Outside Stock Equity — — — —
Total Non Current Liabilities 19,606 19,527 2,983 3,541
Total Liabilities 10,614 11,856 — —
Shareholders' Equity
Preferred Stock Equity — — — —
Common Stock Equity 13,085 21,949 30,052 35,176
Common Par — — — —
Additional Paid in Capital 167,233 165,774 163,406 161,497
Cumulative Translation Adjustment — — — —
Retained Earnings -154,143 -143,831 -133,435 -126,369
Treasury Stock — — — —
Other Equity Adjustments -5 6 81 48
Total Capitalization 23,628 33,783 30,052 35,176
Cash Flow -35,447 -30,716 -26,441 -26,300
Working Capital 17,244 26,774 29,291 34,385
Free Cash Flow -21,503 -12,427 -7,339 -21,546
Invested Capital 23,628 33,783 30,052 35,176
Total Equity 13,085 21,949 30,052 35,176
Total Liabilities and Stock Equity 32,691 41,476 33,035 38,717